Close

Tandem Diabetes (TNDM) Tops Q2 EPS by 14c

Go back to Tandem Diabetes (TNDM) Tops Q2 EPS by 14c

Tandem Diabetes Care Announces Second Quarter 2021 Financial Results and Updated Full Year 2021 Sales Guidance

August 4, 2021 4:05 PM EDT

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2021 and updated its sales guidance for the year ending December 31, 2021.

Second Quarter 2021 Highlights

In comparing the second quarter of 2021 to the same period of 2020:

Worldwide pump shipments increased 81 percent to 33,817 pumps from 18,687 pumps Sales increased 58 percent to $172.1 million from $109.2 million Gross margin improved to 54 percent of sales from 50 percent of sales Operating margin... More